SN-22

SN-22
Identifiers
	IUPAC name 3-(1-methylpiperidin-4-yl)-1H-indole;
CAS Number	17403-07-5 [pubchem];
PubChem CID	11206672;
ChemSpider	9381734 ;
UNII	7NSM99C49F;
ChEMBL	ChEMBL341485;
CompTox Dashboard (EPA)	DTXSID90169751 ;
Chemical and physical data
Formula	C14H18N2
Molar mass	214.312 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN1CCC(CC1)c1c[nH]c2c1cccc2;
	InChI InChI=1S/C14H18N2/c1-16-8-6-11(7-9-16)13-10-15-14-5-3-2-4-12(13)14/h2-5,10-11,15H,6-9H2,1H3; Key:KYSCKYJNMTUJPA-UHFFFAOYSA-N;

SN-22 is a chemical compound which acts as a moderately selective agonist at the 5-HT₂ family of serotonin receptors, with a K_i of 19nM at 5HT₂ subtypes vs 514 nM at 5-HT_1A receptors.^[1] Many related derivatives are known, most of which are ligands for 5-HT_1A, 5-HT₆ or dopamine D₂ receptors or show SSRI activity.^[2]^[3]^[4]^[5]^[6]

References

^ Taylor EW, Nikam SS, Lambert G, Martin AR, Nelson DL (July 1988). "Molecular determinants for recognition of RU 24969 analogs at central 5-hydroxytryptamine recognition sites: use of a bilinear function and substituent volumes to describe steric fit". Molecular Pharmacology. 34 (1): 42–53. PMID 3393140.
^ Agarwal A, Pearson PP, Taylor EW, Li HB, Dahlgren T, Herslöf M, et al. (December 1993). "Three-dimensional quantitative structure-activity relationships of 5-HT receptor binding data for tetrahydropyridinylindole derivatives: a comparison of the Hansch and CoMFA methods". Journal of Medicinal Chemistry. 36 (25): 4006–14. doi:10.1021/jm00077a003. PMID 8258822.
^ Cole DC, Ellingboe JW, Lennox WJ, Mazandarani H, Smith DL, Stock JR, et al. (January 2005). "N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists". Bioorganic & Medicinal Chemistry Letters. 15 (2): 379–83. doi:10.1016/j.bmcl.2004.10.064. PMID 15603958.
^ Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, et al. (June 2007). "Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors". Bioorganic & Medicinal Chemistry Letters. 17 (11): 3099–104. doi:10.1016/j.bmcl.2007.03.040. PMID 17391962.
^ Mattsson C, Andreasson T, Waters N, Sonesson C (November 2012). "Systematic in vivo screening of a series of 1-propyl-4-arylpiperidines against dopaminergic and serotonergic properties in rat brain: a scaffold-jumping approach". Journal of Medicinal Chemistry. 55 (22): 9735–50. doi:10.1021/jm300975f. PMID 23043306.
^ US 6046215, "Inhibition of serotonin reuptake"

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[1] Taylor EW, Nikam SS, Lambert G, Martin AR, Nelson DL (July 1988). "Molecular determinants for recognition of RU 24969 analogs at central 5-hydroxytryptamine recognition sites: use of a bilinear function and substituent volumes to describe steric fit". Molecular Pharmacology. 34 (1): 42–53. PMID 3393140.

[2] Agarwal A, Pearson PP, Taylor EW, Li HB, Dahlgren T, Herslöf M, et al. (December 1993). "Three-dimensional quantitative structure-activity relationships of 5-HT receptor binding data for tetrahydropyridinylindole derivatives: a comparison of the Hansch and CoMFA methods". Journal of Medicinal Chemistry. 36 (25): 4006–14. doi:10.1021/jm00077a003. PMID 8258822.

[3] Cole DC, Ellingboe JW, Lennox WJ, Mazandarani H, Smith DL, Stock JR, et al. (January 2005). "N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists". Bioorganic & Medicinal Chemistry Letters. 15 (2): 379–83. doi:10.1016/j.bmcl.2004.10.064. PMID 15603958.

[4] Deskus JA, Epperson JR, Sloan CP, Cipollina JA, Dextraze P, Qian-Cutrone J, et al. (June 2007). "Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors". Bioorganic & Medicinal Chemistry Letters. 17 (11): 3099–104. doi:10.1016/j.bmcl.2007.03.040. PMID 17391962.

[5] Mattsson C, Andreasson T, Waters N, Sonesson C (November 2012). "Systematic in vivo screening of a series of 1-propyl-4-arylpiperidines against dopaminergic and serotonergic properties in rat brain: a scaffold-jumping approach". Journal of Medicinal Chemistry. 55 (22): 9735–50. doi:10.1021/jm300975f. PMID 23043306.

[6] US 6046215, "Inhibition of serotonin reuptake"

[1]

[2]

[3]

[4]

[5]

[6]

See also

References